© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Shining The Light On A Medical Marvel
Posted 18th December 2019

Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

In 2019 alone, nearly nine million people will have died of cancer. If left unchecked, that figure could well rise to over thirteen million every year by 2030. That is a staggering 1,500 deaths per hour. With these statistics in mind, breakthrough technologies represent one of the greatest hopes for cancer patients of both the present and future. Innovative CEOs such as Nicolas Serandour are standing steadfast as medical vanguards, relentlessly pursuing start-of-the-art technologies that can be leveraged in the ongoing fight against cancer.

Conventional treatments for cancer patients include radiation therapy, which is used in up to sixty percent of cases. However, it can come with costly side effects for the patients. Healthy tissue can suffer, causing internal damage that is hard to repair. That’s where Advanced Oncotherapy’s ground-breaking solution comes in. Focused on proton therapy, also known as proton beam therapy, Nicolas has spearheaded a venture that he believes will revolutionise the way physicians treat cancer moving forward. What separates proton therapy from traditional radiation therapy is the ability to target cancerous cells in the body without causing significant damage to the surrounding healthy tissue.
Advanced Oncotherapy’s vision for the future is one where a more affordable, proton-based radiotherapy system saves the lives of countless more cancer patients than ever before. With this innovative new technology proving to be both cost-effective and clinically superior to existing systems, Nicolas wants to make this vision a reality. Since being at the firm, Nicolas has overseen the development of its proprietary proton-based technology, LIGHT®.

Developed in collaboration with the world-renowned CERN in Switzerland, LIGHT® represents the next step in proton beam therapy and particle acceleration that will change the way cancer is approached. LIGHT®’s compact design allows the delivery of proton beams onto a tumour with greater precision, even during organ movement. This is due to LIGHT®’s capability to change the dose and energy very quickly, which is important for an entire class of moving tumours (lung, pancreatic, liver).

Nicolas and his team are also capitalising on LIGHT®’s uniquely small beam size to position the device ahead in the race for delivering what is called “FLASH”: a faster, cheaper approach to proton therapy. A research collaboration with the Cleveland Clinic, that will evaluate the target conformity of proton minibeams, is a significant development as it marks a clear endorsement from one of the most prestigious healthcare institutions in the world.

“Advanced Oncotherapy’s vision for the future is to save the lives of countless more cancer patients than ever before.”

The company has many ongoing discussions and exclusivity arrangements across the world, including great interest from China. Rather than simply boast about a new piece of tech, and expect hospitals to buy it, Nicolas has instead focused on building relationships that are clinically beneficial for all involved. By enabling hospitals to be a part of developing this new particle accelerator and investigating its therapeutic uses, Advanced Oncotherapy and LIGHT® have rapidly become compelling partners.

Nicolas’ success as CEO of Advanced Oncotherapy will soon see the first LIGHT® system implemented in Harley Street, London. An iconic medical location, this latest development sees yet another success secured for Nicolas and his team. As a proton beam accelerator that is far more compact that traditional radiology equipment, LIGHT® being implemented in the basement of two terraced houses in London will hopefully prove that it can be implemented almost anywhere.

Of course, the mark of any great CEO is the ability to recognise the incredible work of the team around them. Since the beginning of his tenure with Advanced Oncotherapy, Nicolas has remained indebted to the outstanding work and devotion of his staff in pursuing their one goal together; to save lives. Nicolas instils in his staff the energy and desire to work collectively as a team in meeting technical milestones set almost thirty months ago. Hiring and partnering with high-calibre experts in radiation and proton therapy, the team Nicolas has built is as much a testament to his success as that of LIGHT® itself.

For Nicolas, the next step is getting LIGHT® into hospitals where it can truly change lives for the better. A well-considered implementation plan is already in place to successfully transform Advanced Oncotherapy into the undisputed commercial leader for proton-based therapy. As the next decade beckons, while Nicolas remains one of the most exciting leaders to watch within oncotherapy, it is his firm’s potential to radically advance humanity’s efforts to defeat cancer for good that is the real draw.

Company: Advanced Oncotherapy
Contact: advancedoncotherapy@fticonsulting.com
Website: https://www.avoplc.com/

Categories: Innovation, Leadership, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Asia Pacific Liquefied Petroleum Gas Market is Expected to Reach $100 Billion
Finance
27/02/2015Asia Pacific Liquefied Petroleum Gas Market is Expected to Reach $100 Billion

Market expected to reach $100 billion by 2019, at a CAGR of 5.3% From 2014 to 2019

Read Full PostRead - Eye Icon
Growing Your Business? The Legal Checks That Make the Next Step Easier
Legal
11/11/2026Growing Your Business? The Legal Checks That Make the Next Step Easier

So your business is doing well, and you’re thinking about the next big step. Maybe it’s a second location. Maybe an investor has offered to help you grow faster. Either way, it’s exciting, and it’s also the moment when a few quick signa

Read Full PostRead - Eye Icon
Intertek Acquires MT Group
M&A
27/10/2015Intertek Acquires MT Group

Intertek gains new geotechnical and materials services and expands US Building sector with footprint into the New York Metro area.

Read Full PostRead - Eye Icon
Award Winning Cloud-Based Communication
Innovation
04/05/2022Award Winning Cloud-Based Communication

Unified Communications as a Service (UCaaS) is a category of "as a service" or "Cloud" delivery mechanisms for enterprize communications. These procedures allow the linking of data between one source to another, in no time.

Read Full PostRead - Eye Icon
Ones to Watch in IP, 2016 California
Legal
04/04/2016Ones to Watch in IP, 2016 California

West & Associates is a full-service law firm specializing in the practice of Intellectual Property law.

Read Full PostRead - Eye Icon
Small Businesses Are Less Optimistic but May Still Need Additional Credit
Finance
20/08/2015Small Businesses Are Less Optimistic but May Still Need Additional Credit

During the third quarter of 2015, small businesses and middle market companies appear to be less optimistic as the year comes to a close and many are in the midst of budget planning.

Read Full PostRead - Eye Icon
New Ofcom Report a Threat to BT
Finance
20/07/2015New Ofcom Report a Threat to BT

The results of the first phase of Ofcom’s Strategic Review of Digital Communications poses threat to the telecommunication firm, with concerns over BT’s market share and speed of repairs and line installations.

Read Full PostRead - Eye Icon
Structural Differences Between Futures and Spread Contracts
Finance
26/10/2026Structural Differences Between Futures and Spread Contracts

Futures and spread bets give traders access to many of the same markets, from equity indices and currencies to commodities and government bonds. On a price chart, the two can look almost interchangeable. Underneath that chart, however, they are built very diff

Read Full PostRead - Eye Icon
Reasons Why IT Support Is More Critical Than Ever For Today’s Businesses
News
31/10/2022Reasons Why IT Support Is More Critical Than Ever For Today’s Businesses

As digital transformation and remote work continue to gain steam, IT services remain absolutely indispensable for businesses of all types and sizes. Whether an in-house team dedicated to the maintenance and upkeep of systems or a reliable outsourced support pr



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow